🇪🇺 Rapamune in European Union

EMA authorised Rapamune on 13 March 2001

Marketing authorisation

EMA — authorised 13 March 2001

  • Marketing authorisation holder: Pfizer Europe MA EEIG
  • Status: approved

Rapamune in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Rapamune approved in European Union?

Yes. EMA authorised it on 13 March 2001.

Who is the marketing authorisation holder for Rapamune in European Union?

Pfizer Europe MA EEIG holds the EU marketing authorisation.